Clinical trials
Obesity and Type 2 Diabetes clinical trials
Below are recruiting obesity and type 2 diabetes clinical trials, each written for real people, not researchers. We’re tracking 276 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07095543Recruiting
Plant-based weight loss through online program
This study tests an online weight loss program based on a plant-based diet. You may be able to join if you live in the U.S., are overweight, can travel to Washington DC for a body scan, and are not using weight loss medications.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07086989Recruiting
Heart health study for kids with chronic conditions
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
BudapestAges 6–25 - NCT06152588Recruiting
Time-restricted eating for type 2 diabetes
This trial tests if eating only during a restricted time window each day can help control blood sugar in people with type 2 diabetes. If you have type 2 diabetes, are overweight, and usually eat over a long period each day, you may be able to join.
Herlev, DenmarkAges 18 years+ - NCT06959043Recruiting
Diet and exercise for type 2 diabetes
This study tests if a plant-based diet and exercise program can improve blood sugar control in people with type 2 diabetes. Participants will live in a hospital for 4 weeks to follow the program closely.
São Paulo, São PauloAges 45–70 - NCT06983054RecruitingPhase 4
Salt, kidneys, and ertugliflozin in type 2 diabetes
This study tests if changing how much salt you eat affects how the drug ertugliflozin works in people with type 2 diabetes. You would take either the drug or a placebo (a dummy pill) for a short time while following a low- or high-salt diet, to see how your kidneys and blood vessels respond.
Denver, ColoradoAges 18–85 - NCT01793168Recruiting
Rare disease registry and history study
This study keeps a registry (a structured list) of people with rare diseases and may also track how the condition changes over time. It can help researchers better understand rare illnesses and find gaps in care, which may improve future treatments.
Sioux Falls, South DakotaAges Any age - NCT07017127Recruiting
Remission of type 2 diabetes with lifestyle changes
This trial tests whether a lifestyle program can help people recently diagnosed with type 2 diabetes achieve remission. It focuses on diet and physical activity, not medications.
SplitAges 20–69 - NCT06993454Recruiting
Exercise and blood sugar in type 2 diabetes with fatty liver
This study looks at how a single session of exercise affects the body's natural sugar production in people with type 2 diabetes and fatty liver. It may help us find better ways to control blood sugar and treat fatty liver.
Orlando, FloridaAges 25–55 - NCT03455868Recruiting
Bone health check after bariatric surgery in people with diabetes
This study looks at how bariatric (weight-loss) surgery affects bone health in adults with type 2 diabetes. It may help doctors understand who needs extra bone protection after surgery.
Montreal, QuebecAges 18–60 - NCT06953180Recruiting
Epigenetics, aging, and disease prevention study in Kazakhstan
This study looks at how your genes and environment affect your risk for non-communicable diseases like heart disease or diabetes. It aims to predict your biological age and help create personalized prevention plans.
Almaty, KazakhstanAges 18–69 - NCT06959901Recruiting
Health tracking app study for Hispanic teens
This trial tests a mobile app that helps teens keep track of their health habits, like physical activity and eating. It is designed for Hispanic or Latino teens ages 12-18 who have a BMI in a certain range and own an iPhone.
Houston, TexasAges 12–18 - NCT06943001Recruiting
Telehealth program to prevent diabetes in Hispanic teens
This trial tests a telehealth program to help Hispanic teens who are obese prevent type 2 diabetes. It takes place from home and uses your own cellphone.
Houston, TexasAges 14–16 - NCT06937203RecruitingPhase 1/Phase 2
A new obesity drug study for people with or without type 2 diabetes
This early-stage study tests an investigational drug called ARO-ALK7 to see if it helps adults with obesity lose weight. It includes people who have type 2 diabetes as well as those who do not, and requires that you have tried to lose weight with lifestyle changes in the past.
Morayfield, QLCAges 18–65 - NCT06923644Recruiting
Personalized nutrition plan to prevent metabolic disease
This study tests whether a personalized nutrition plan based on your unique metabolism can help prevent chronic metabolic diseases like type 2 diabetes. You will follow a tailored diet and have your health monitored over time.
MaastrichtAges 40–75 - NCT06923735Enrolling by invitation
Nutrition app pilot for employee health checks
This pilot study tests a nutrition app to help employees manage conditions like high cholesterol, high blood pressure, weight issues, or type 2 diabetes. It is part of your regular occupational health check or dietitian visit.
KuopioAges 18–75 - NCT06926166Recruiting
Genes and germs in early life study
This study looks at how genes and tiny organisms in your body (microbiota) affect early childhood development. It involves storing blood and stool samples from you and your child to help researchers learn more.
GuangzhouAges Any age - NCT06907862Recruiting
SWITCH trial: swapping processed soy foods in a heart-healthy diet
This study tests whether swapping highly processed soy foods for less processed soy foods, as part of a heart-healthy diet, can improve blood pressure, blood sugar, and weight in adults with obesity and high blood pressure. It may be a good option if you have type 2 diabetes and are already on stable medications.
Toronto, OntarioAges 18 years+ - NCT06897475RecruitingPhase 2
Study of LY3457263 for type 2 diabetes on semaglutide or tirzepatide
This study tests if adding LY3457263 helps lower blood sugar in people with type 2 diabetes who are already taking a stable dose of semaglutide or tirzepatide. You will be randomly assigned to get either LY3457263 or a placebo.
Phoenix, ArizonaAges 18–75 - NCT06830096Recruiting
Understanding a key cell channel in type 2 diabetes
This study looks at how a specific channel in your cells (called the KATP channel) affects blood sugar control in people with and without type 2 diabetes. It aims to understand why some people develop diabetes and how to better treat it.
St Louis, MissouriAges 18–65 - NCT06211556Recruiting
Reducing liver fat in type 2 diabetes
This study tests whether reducing liver fat can improve health in people with type 2 diabetes. It looks at the effects of a specific medication combined with exercise, tailored for those who are not very active.
Copenhagen, Capital RegionAges 30–70 - NCT06782139RecruitingPhase 4
Enavogliflozin for heart health in obesity and diabetes
This trial tests if Enavogliflozin, a medication for diabetes, can improve blood flow in the small vessels of the heart and overall heart function in people with obesity or diabetes. You may join if you have obesity or diabetes and have had a recent heart test.
SeoulAges 20–79 - NCT06772168RecruitingPhase 3
New combo pill for diabetes and high cholesterol
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
AnyangAges 19–80 - NCT06730113Recruiting
Young adults with type 2 diabetes and heart health study
This study looks at how type 2 diabetes starting in youth affects the heart over time. It also includes teens and young adults who are overweight or lean, and their biological parents, to compare heart health across these groups.
Washington D.C., District of ColumbiaAges 12–25 - NCT06169033Recruiting
Can belly fat scans predict weight-loss surgery success?
This study looks at how fat around your belly and inside your abdomen, seen on a CT scan, can predict how well bariatric (weight-loss) surgery will work for people with type 2 diabetes.
BeijingAges 16–70
Hear when a new Obesity and Type 2 Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity and type 2 diabetes?
- Yes. Clin2 currently lists 276 recruiting obesity and type 2 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity and type 2 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity and type 2 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.